4 results about "Deep tissue imaging" patented technology

The present application relates to a kind of electron donor (alpha-trithiophene) modified rhodamine dye, its synthesis method and application.The dye has strong absorption of 500-600 nm, can emit efficiently in 550-700 nm band, suitable for deep tissue imaging.The structure endows mitochondria targeting ability, can be used as biomarker probe to realize subcellular organelle accurate positioning;Meanwhile, under light, it can efficiently produce reactive oxygen species through type I mechanism, suitable for the photodynamic regulation and biosensing for non-disease diagnosis and treatment purposes.In addition, the dye can also be used as organic photocatalyst for environmental or energy-related photocatalytic reaction.The present application provides a new choice for multi-scene optoelectronic functional materials.

This invention discloses a computationally adaptive aberration correction imaging method for deep tissue based on upconversion nanoparticle guide stars. A near-infrared fluorescence imaging system is constructed using rare-earth upconversion nanoparticles as guide stars. Fluorescence distortion images of deep tissue samples are acquired through near-infrared excitation, and imaging aberrations are parameterized based on Zernike polynomials. Aberration coefficients are reconstructed using a deep learning model incorporating physical prior constraints. Digital wavefront compensation is performed based on the reconstructed aberration information to achieve deep tissue aberration correction and obtain high-resolution imaging results. This invention eliminates the need for complex optical hardware such as wavefront sensors or deformable mirrors, and can stably achieve aberration estimation and compensation even in 360 μm deep tissue conditions. Compared with traditional aberration correction methods, the correction effect is improved by more than 30%, enabling rapid image correction and high-precision positioning. It solves the problems of weak guide star signals, low aberration correction efficiency, and high system cost in deep tissue imaging, and is applicable to deep tissue optical imaging in fields such as clinical diagnosis, biological cell observation, and drug development.

The application discloses a ratio type near-infrared fluorescent probe based on an ICT-FRET mechanism and a preparation method and application thereof. The ratio type near-infrared fluorescent probe based on the ICT-FRET mechanism emits in a near-infrared region, has an ultra-large stokes shift, can effectively avoid excitation light interference and self-absorption, reduces biological background fluorescence, and is suitable for deep tissue imaging. The probe can realize double-emission ratio response (I 660 / I 540 ) based on the FRET mechanism, has a significant signal change, has inherent self-calibration capability, shows extremely high selectivity to Cys, has almost no response to Hcy and GSH similar in structure, is strong in anti-environmental interference, and is more accurate in quantification. The TPP targeting group of the probe enables the probe to be specifically positioned in mitochondria of living cells, realizes dynamic ratio imaging of endogenous and exogenous Cys in mitochondria, and provides a powerful tool for studying Cys metabolism at a subcellular level.

This invention relates to the field of biodetection technology, specifically to a NO-responsive near-infrared II fluorescent probe, its preparation method, and its application. The structure of the fluorescent probe is shown below. The fluorescent probe TD-OT-BNH2 of this invention exhibits high sensitivity to NO and a low detection limit, meeting the needs for trace NO detection. This fluorescent probe demonstrates good selectivity and anti-interference ability against common metal ions, anions, biothiols, and reactive oxygen species. After reacting with NO, both the absorption and emission spectra of the fluorescent probe undergo a significant redshift, generating a clear fluorescence signal within the NIR-II imaging window, suitable for deep tissue imaging. The fluorescent probe possesses aggregation-induced emission properties, which enhances its fluorescence imaging performance in complex biological environments. This fluorescent probe exhibits low cytotoxicity and good biocompatibility, and can be used for visual detection of nitric oxide at the cellular and in vivo levels.